Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Cataract - Overview
Cataract - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Cataract - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Cataract - Companies Involved in Therapeutics Development
Calpain Therapeutics Pty Ltd
Cellix Bio Pvt Ltd
CGeneTech (Suzhou Chi) Co Ltd
Dhp Korea Ltd
Genisphere LLC
Kubota Vision Inc
cuity Pharmaceuticals Inc
Plex Pharmaceuticals Inc
Reven Pharmaceuticals Inc
ViewPoint Therapeutics Inc
Vitreo Pharma Inc
Cataract - Drug Profiles
CAP-1160 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CAP-4196 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CAT-811 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CGT-1507 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CLXOPH-65 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DHPNP-06 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GL-249 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NPI-002 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RPEC-1007a - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule for Presbyopia and Cataract - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit NFkB for Ophthalmology, Oncology, Dermatology, Immunology and Infectious Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tafamidis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
VP-1001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
VT-1001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ZOC-2017217 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cataract - Dormant Projects
Cataract - Discontinued Products
Cataract - Product Development Milestones
Featured News & Press Releases
May 01, 2018: ViewPoint Appoints Dr. Robert Kim as Chief Medical Officer
Sep 07, 2016: Plex Pharmaceuticals awarded $299,173 NIH Phase I SBIR grant funding to find non-surgical treatments for Cataracts
May 13, 2012: Calpain Therapeutics Wins Commercialisation Australia Grant To Progress Anti-Cataract Programme
Sep 04, 2011: New Drug Eyes Way To Beat Cataracts
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Cataract, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Cataract, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Cataract - Pipeline by Calpain Therapeutics Pty Ltd, 2021
Cataract - Pipeline by Cellix Bio Pvt Ltd, 2021
Cataract - Pipeline by CGeneTech (Suzhou China) Co Ltd, 2021
Cataract - Pipeline by Dhp Korea Ltd, 2021
Cataract - Pipeline by Genisphere LLC, 2021
Cataract - Pipeline by Kubota Vision Inc, 2021
Cataract - Pipeline by Nacuity Pharmaceuticals Inc, 2021
Cataract - Pipeline by Plex Pharmaceuticals Inc, 2021
Cataract - Pipeline by Reven Pharmaceuticals Inc, 2021
Cataract - Pipeline by ViewPoint Therapeutics Inc, 2021
Cataract - Pipeline by Vitreo Pharma Inc, 2021
Cataract - Dormant Projects, 2021
Cataract - Discontinued Products, 2021